Nutrien (NYSE:NTR) Issues Earnings Results

Nutrien (NYSE:NTRGet Free Report) released its earnings results on Wednesday. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09), Zacks reports. The business had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%.

Nutrien Price Performance

NTR traded up $0.97 during midday trading on Thursday, reaching $53.42. 693,213 shares of the company’s stock were exchanged, compared to its average volume of 2,234,598. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The stock has a market capitalization of $26.17 billion, a PE ratio of 35.83, a P/E/G ratio of 1.16 and a beta of 0.81. The business’s 50-day moving average price is $49.22 and its 200 day moving average price is $48.16. Nutrien has a 1-year low of $43.69 and a 1-year high of $60.87.

Analyst Upgrades and Downgrades

NTR has been the topic of a number of research reports. JPMorgan Chase & Co. upgraded shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $40.00 to $50.00 in a report on Monday, January 13th. Piper Sandler increased their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. CIBC reiterated an “outperformer” rating and set a $55.00 target price (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. UBS Group increased their target price on shares of Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a report on Thursday. Finally, TD Securities reduced their price objective on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $59.06.

Check Out Our Latest Research Report on Nutrien

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Earnings History for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.